Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
Lung cancer is one of the kinds of cancer that is most likely to spread to the brain. Approximately 20 percent of lung cancer patients develop brain metastases. And roughly 10 to 20 percent of people ...
A new study by researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is ...
The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior ...
HOUSTON, TX / ACCESS Newswire / March 4, 2026 / BrYet US, Inc. ("BrYet") - a biotechnology innovator focused on ...
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results